In vitro biofilm formation by multidrug resistant clinical isolates of Pseudomonas aeruginosa
DOI:
https://doi.org/10.3329/ajmbr.v4i1.36828Keywords:
wound infection, Pseudomonas aeruginosa, multidrug resistance, MIC, MBC, biofilmAbstract
In this study, 15 isolates of Pseudomonas aeruginosa were recovered in Cetrimide agar medium from aseptically collected swab samples. Antibiotic susceptibility test revealed highest resistance against Rifampicin (100%) followed by Penicillin (80%), Erythromycin (73.33%), Cephalosporin group (13.33-60%) and Aminoglycoside group (26.67%). The most effective group of antibiotic was Carbapenem with 6.67% resistance. Among 15 isolates, 3 were having highest Multiple Antibiotic Resistance (MAR) index were identified as Pseudomonas aeruginosa (P1, P2 and P3) by API®20NE microbial identification kit. Minimum inhibitory concentration (MIC) of the isolates P1, P2 and P3 was 3.05μg/mL, 0.76μg/mL and 3.05μg/mL for Meropenem whereas for Ceftriaxone it was 12.207μg/mL, 12.207μg/mL and 781.25μg/mL, respectively. Minimum bactericidal concentration (MBC) of Meropenem and Ceftriaxone was same for the isolates P1 and P2 i.e., 48.83μg/mL and 195.313μg/mL, respectively but in case of P3 it was 781.25μg/mL for both antibiotics. In case of 70% ethanol, the MIC and MBC was 1:4 dilutions (for isolate P3, MBC was 1:2 dilutions) whereas for Savlon®, MIC and MBC was 1% and 2% solution, respectively. All of the three isolates were biofilm former according to test tube assay and microtitre plate assay whereas modified congo red agar assay indicated only one isolate as biofilm former. The results suggest that post-operative wound infection may serve as a reservoir for multidrug resistant biofilm forming P. aeruginosa which may complicate the treatment regime unless proper treatment ensured based on antibiotic/antiseptic susceptibility test.
Asian J. Med. Biol. Res. March 2018, 4(1): 105-116
Downloads
870
803
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms / The author(s) affirm(s) that:
- The manuscript submitted is based on authors own research and is original work.
- Authors certify that we all participated in the research work and preparation of the manuscript in a substantive way.
- Authors also declare that they have read and approved the manuscript.
- Authors further declare that the manuscript has not been published in part or full and is not being submitted or considered for publication in part or full elsewhere.
- Any material included in the manuscript does not violate copyright or other rights of anyone.
- Authors also affirm that the article contains no vilifying or unlawful statements and does not contain material or instructions that might cause harm or injury to the Editor-in-Chief/Editors of the Journal and the public.
- Authors assure Asian J. Med. Biol. Res. and the Editor-in-Chief/Editors of the Journals, and hold them harmless from any loss, expense or damage occurred by a claim or suit by a third party for copyright violation, or any suit arising out of any violation of the foregoing warranties as a result of publication of my/our article.
- In consideration of authors manuscript submitted, authors hereby grant Asian J. Med. Biol. Res. unlimited, worldwide, permanent royalty-free, right to publish, use, dispense, license, transmit, display, exhibit, record, store, translate, digitize, broadcast, reproduce and archive, in any format or medium, whether now known or developed hereafter.
All materials related to manuscripts, accepted or rejected, including photographs, original figures etc., will be kept by Asian J. Med. Biol. Res. for one year following the editors decision. These materials will then be destroyed.
